Myriad Genetics's total assets for Q3 2025 were $728.10M, an increase of 7.50% from the previous quarter. MYGN total liabilities were $355.30M for the fiscal quarter, a 22.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.